Diabetes and Endocrinology Trials

A collection of visual abstracts of landmark clinical trials in diabetes care and endocrinology.

Course Content

Expand All
Important Trials in Diabetes and Endocrinology 2021 14 Topics
Expand
Lesson Content
0% Complete 0/14 Steps
Diabetes Mellitus 24 Topics
Expand
Lesson Content
0% Complete 0/24 Steps
ADVANCE : Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
ACCORD : Effects of intensive glucose lowering in type 2 diabetes
CANVAS : Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
D2d TRIAL: Vitamin D Supplementation and Prevention of Type 2 Diabetes.
DCCT : The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
DPP: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The Diabetes Prevention Program
HAPO: Hyperglycemia and Adverse Pregnancy Outcomes. The HAPO Study Cooperative Research Group
LEADER : Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial
Look AHEAD – Look Action for HEAlth in Diabetes.
NICE-SUGAR : Intensive versus conventional glucose control in critically ill patients
CREDENCE
DAPA-HF: Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
DECLARE-TIMI 58
iDCL: The international Diabetes Closed Loop Trial: The Clinical Acceptance of the Artificial Pancreas
Look AHEAD: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Look Action for HEAlth in Diabetes.
RENAAL: Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan
UKPDS 33
U500-R (“HOOD study”)
PROactive
1 of 2
>